MYGNMyriad Genetics, Inc.

$454M

FY 2017 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$773M+0.2% YoY

Gross Profit

$595M77.1% margin

Operating Income

$119M15.4% margin

Net Income

$131M17.0% margin

EPS (Diluted)

$1.82

Cash Flow

Operating Cash Flow

$116M

Free Cash Flow

$108M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$209M

Stockholders' Equity

$965M

Cash & Equivalents

$111M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$773M	$771M	+0.2%
Gross Profit	$595M	$600M	-0.8%
Operating Income	$119M	$49M	+140.3%
Net Income	$131M	$22M	+500.9%

MYGN FY 2017 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena